Point72 Asset Management’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 1761 |
|
2025
Q1 | – | Sell |
-249,003
| Closed | -$6.35M | – | 1732 |
|
2024
Q4 | $6.35M | Sell |
249,003
-277,630
| -53% | -$7.08M | 0.01% | 636 |
|
2024
Q3 | $14.9M | Buy |
+526,633
| New | +$14.9M | 0.04% | 415 |
|
2024
Q2 | – | Sell |
-521,200
| Closed | -$15.8M | – | 1690 |
|
2024
Q1 | $15.8M | Sell |
521,200
-647,600
| -55% | -$19.7M | 0.04% | 481 |
|
2023
Q4 | $32.8M | Buy |
1,168,800
+440,600
| +61% | +$12.4M | 0.08% | 280 |
|
2023
Q3 | $19.8M | Buy |
728,200
+198,000
| +37% | +$5.37M | 0.06% | 371 |
|
2023
Q2 | $16.3M | Sell |
530,200
-88,600
| -14% | -$2.72M | 0.05% | 400 |
|
2023
Q1 | $22.3M | Buy |
+618,800
| New | +$22.3M | 0.07% | 301 |
|
2022
Q2 | – | Sell |
-1,892,900
| Closed | -$73.7M | – | 1295 |
|
2022
Q1 | $73.7M | Buy |
1,892,900
+1,556,800
| +463% | +$60.7M | 0.29% | 71 |
|
2021
Q4 | $13.4M | Buy |
336,100
+277,000
| +469% | +$11M | 0.05% | 413 |
|
2021
Q3 | $2.14M | Buy |
+59,100
| New | +$2.14M | 0.01% | 726 |
|